- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
UCSF Chancellor to Assume Helm at Gates Foundation
18 December 2013 1:45 pm
Susan Desmond-Hellmann, the chancellor of the University of California, San Francisco (UCSF), will be the next CEO of the Bill & Melinda Gates Foundation. The oncologist and former Genentech executive will take the reins of the huge philanthropy from retiring CEO Jeff Raikes on 1 May 2014, overseeing the foundation’s activities in global public health, poverty, and education.
Before assuming the post as UCSF chancellor in 2009, Desmond-Hellmann was president of product development at pre-Roche Genentech “during some of the biotech’s most fruitful years,” according to FierceBiotech, leading the introduction of the targeted cancer drugs Avastin and Herceptin. Desmond-Hellmann was one of the few oncologists on staff at Genentech, says The New York Times, and was in charge of all clinical trials.
“Sue’s background in public health policy, research and development, and higher education, make her an exceptional fit for this role,” said Bill Gates, co-chair of the foundation, in a statement.